Nexium Mups (Esomeprazole Magnesium Trihydrate)

Esomeprazole magnesium trihydrate irreversibly inhibits the H+/K+ ATPase enzyme, also known as the gastric proton pump, on the secretory surface of parietal cells. By blocking this final step of acid secretion, it markedly lowers gastric acidity, providing relief from acid‑related conditions.

The appropriate dose of Nexium Mups is determined by the prescribing healthcare professional based on the patient’s specific condition, severity, and response to therapy. Dosage may vary, and patients should follow the prescriber’s instructions without making any changes on their own.

Safety data for esomeprazole magnesium trihydrate in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Nexium Mups delivers esomeprazole, the S‑enantiomer of omeprazole, offering a more consistent pharmacokinetic profile and potentially improved acid control compared with racemic PPIs. It is generally considered as effective as other proton pump inhibitors but may have a different interaction profile with certain medications.

Nexium Mups should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original container, protect it from moisture and direct sunlight, and ensure the packaging remains tightly closed until use.

Nexium Mups is taken orally, usually swallowed whole with a glass of water. It may be taken with or without food, but patients should follow the specific instructions provided by their prescriber to achieve optimal therapeutic effect.

Serious but rare adverse events include Clostridioides difficile‑associated colitis, acute interstitial nephritis, and severe skin reactions such as Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience persistent diarrhea, unexplained kidney problems, or any severe rash.

Nexium Mups is contraindicated in individuals with known hypersensitivity to esomeprazole, other proton pump inhibitors, or any of the product’s excipients. Patients with severe hepatic impairment should avoid use, and those with a history of serious drug interactions should be evaluated carefully by their clinician.